Perrigo Company (PRGO) - Bull of the Day

Perrigo Company (PRGO) reported first quarter fiscal 2011 EPS of $0.87, well above the Zacks Consensus Estimate of $0.77. We believe that Perrigo's strong position in the brand OTC pharmaceutical market and growing generics and API businesses will help it deliver solid top- and bottom-line growth in the coming years.

We also expect the company to benefit from OTC switches from branded products in the next five years. Moreover, management's policy of pursuing on smart strategic deals will continue to drive growth for the company.

Perrigo also has a very strong and impressive pipeline. We, therefore, initiate coverage on the stock with an Outperform rating.
 
PERRIGO COMPANY (PRGO): Free Stock Analysis Report
 
Zacks Investment Research